These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 25706874)
1. LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes. Li P; Oh DY; Bandyopadhyay G; Lagakos WS; Talukdar S; Osborn O; Johnson A; Chung H; Maris M; Ofrecio JM; Taguchi S; Lu M; Olefsky JM Nat Med; 2015 Mar; 21(3):239-247. PubMed ID: 25706874 [TBL] [Abstract][Full Text] [Related]
3. Adipose tissue B2 cells promote insulin resistance through leukotriene LTB4/LTB4R1 signaling. Ying W; Wollam J; Ofrecio JM; Bandyopadhyay G; El Ouarrat D; Lee YS; Oh DY; Li P; Osborn O; Olefsky JM J Clin Invest; 2017 Mar; 127(3):1019-1030. PubMed ID: 28192375 [TBL] [Abstract][Full Text] [Related]
4. Hepatocyte leukotriene B4 receptor 1 promotes NAFLD development in obesity. Liu X; Wang K; Wang L; Kong L; Hou S; Wan Y; Ma C; Chen J; Xing X; Xing C; Jiang Q; Zhao Q; Cui B; Huang Z; Li P Hepatology; 2023 Aug; 78(2):562-577. PubMed ID: 35931467 [TBL] [Abstract][Full Text] [Related]
5. Deficiency of the leukotriene B4 receptor, BLT-1, protects against systemic insulin resistance in diet-induced obesity. Spite M; Hellmann J; Tang Y; Mathis SP; Kosuri M; Bhatnagar A; Jala VR; Haribabu B J Immunol; 2011 Aug; 187(4):1942-9. PubMed ID: 21742977 [TBL] [Abstract][Full Text] [Related]
6. WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling. Jung TW; Kang C; Goh J; Chae SI; Kim HC; Lee TJ; Abd El-Aty AM; Jeong JH J Cell Physiol; 2018 Aug; 233(8):6077-6087. PubMed ID: 29319180 [TBL] [Abstract][Full Text] [Related]
7. Opposite cross-talk by oleate and palmitate on insulin signaling in hepatocytes through macrophage activation. Pardo V; González-Rodríguez Á; Guijas C; Balsinde J; Valverde ÁM J Biol Chem; 2015 May; 290(18):11663-77. PubMed ID: 25792746 [TBL] [Abstract][Full Text] [Related]
8. Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity. Woo SL; Xu H; Li H; Zhao Y; Hu X; Zhao J; Guo X; Guo T; Botchlett R; Qi T; Pei Y; Zheng J; Xu Y; An X; Chen L; Chen L; Li Q; Xiao X; Huo Y; Wu C PLoS One; 2014; 9(3):e91111. PubMed ID: 24638078 [TBL] [Abstract][Full Text] [Related]
9. Paraoxonase1 (PON1) reduces insulin resistance in mice fed a high-fat diet, and promotes GLUT4 overexpression in myocytes, via the IRS-1/Akt pathway. Koren-Gluzer M; Aviram M; Hayek T Atherosclerosis; 2013 Jul; 229(1):71-8. PubMed ID: 23639858 [TBL] [Abstract][Full Text] [Related]
10. Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice. Liu J; Zhou L; Xiong K; Godlewski G; Mukhopadhyay B; Tam J; Yin S; Gao P; Shan X; Pickel J; Bataller R; O'Hare J; Scherer T; Buettner C; Kunos G Gastroenterology; 2012 May; 142(5):1218-1228.e1. PubMed ID: 22307032 [TBL] [Abstract][Full Text] [Related]
11. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice. Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299 [TBL] [Abstract][Full Text] [Related]
14. A novel benzenediamine derivative FC98 reduces insulin resistance in high fat diet-induced obese mice by suppression of metaflammation. Chen C; Zhang W; Shi H; Zhuo Y; Yang G; Zhang A; Hou Y; Xiang Tan R; Li E Eur J Pharmacol; 2015 Aug; 761():298-308. PubMed ID: 26086863 [TBL] [Abstract][Full Text] [Related]
15. Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance. Li P; Liu S; Lu M; Bandyopadhyay G; Oh D; Imamura T; Johnson AMF; Sears D; Shen Z; Cui B; Kong L; Hou S; Liang X; Iovino S; Watkins SM; Ying W; Osborn O; Wollam J; Brenner M; Olefsky JM Cell; 2016 Nov; 167(4):973-984.e12. PubMed ID: 27814523 [TBL] [Abstract][Full Text] [Related]
16. Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway. Liu K; Luo T; Zhang Z; Wang T; Kou J; Liu B; Huang F J Ethnopharmacol; 2011 Jul; 136(3):473-9. PubMed ID: 21296137 [TBL] [Abstract][Full Text] [Related]
17. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver. Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149 [TBL] [Abstract][Full Text] [Related]
18. Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling. Clementi AH; Gaudy AM; van Rooijen N; Pierce RH; Mooney RA Biochim Biophys Acta; 2009 Nov; 1792(11):1062-72. PubMed ID: 19699298 [TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of yerba maté extract (Ilex paraguariensis) ameliorate insulin resistance in mice with high fat diet-induced obesity. Arçari DP; Bartchewsky W; dos Santos TW; Oliveira KA; DeOliveira CC; Gotardo ÉM; Pedrazzoli J; Gambero A; Ferraz LF; Carvalho Pde O; Ribeiro ML Mol Cell Endocrinol; 2011 Mar; 335(2):110-5. PubMed ID: 21238540 [TBL] [Abstract][Full Text] [Related]
20. Fpr2 Deficiency Alleviates Diet-Induced Insulin Resistance Through Reducing Body Weight Gain and Inhibiting Inflammation Mediated by Macrophage Chemotaxis and M1 Polarization. Chen X; Zhuo S; Zhu T; Yao P; Yang M; Mei H; Li N; Ma F; Wang JM; Chen S; Ye RD; Li Y; Le Y Diabetes; 2019 Jun; 68(6):1130-1142. PubMed ID: 30862681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]